Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CASI Pharmaceuticals (CASI) Return on Sales (2022 - 2025)

Historic Return on Sales for Pharmaceuticals (CASI) over the last 4 years, with Q2 2025 value amounting to 2.6%.

  • Pharmaceuticals' Return on Sales fell 4700.0% to 2.6% in Q2 2025 from the same period last year, while for Jun 2025 it was 2.04%, marking a year-over-year decrease of 9200.0%. This contributed to the annual value of 1.33% for FY2024, which is 5500.0% down from last year.
  • Pharmaceuticals' Return on Sales amounted to 2.6% in Q2 2025, which was down 4700.0% from 1.62% recorded in Q1 2025.
  • Pharmaceuticals' Return on Sales' 5-year high stood at 0.48% during Q4 2023, with a 5-year trough of 2.68% in Q1 2024.
  • Over the past 4 years, Pharmaceuticals' median Return on Sales value was 0.96% (recorded in 2023), while the average stood at 1.3%.
  • In the last 5 years, Pharmaceuticals' Return on Sales plummeted by -18100bps in 2024 and then skyrocketed by 10600bps in 2025.
  • Pharmaceuticals' Return on Sales (Quarter) stood at 1.45% in 2022, then surged by 67bps to 0.48% in 2023, then crashed by -205bps to 1.47% in 2024, then tumbled by -77bps to 2.6% in 2025.
  • Its Return on Sales was 2.6% in Q2 2025, compared to 1.62% in Q1 2025 and 1.47% in Q4 2024.